{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:59:22Z","timestamp":1772225962598,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T00:00:00Z","timestamp":1521763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2014HL090"],"award-info":[{"award-number":["ZR2014HL090"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12941-018-0267-8","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:54:46Z","timestamp":1522799686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven\u00a0years retrospective study in three tertiary care hospitals"],"prefix":"10.1186","volume":"17","author":[{"given":"Feng","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Qin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmed.2012.03.003","volume":"18","author":"P Nordmann","year":"2012","unstructured":"Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263\u201372.","journal-title":"Trends Mol Med"},{"key":"267_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijantimicag.2011.09.014","volume":"39","author":"ML Little","year":"2012","unstructured":"Little ML, Qin X, Zerr DM, Weissman SJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int J Antimicrob Agents. 2012;39:52\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"267_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ajic.2011.11.008","volume":"40","author":"C Lowe","year":"2012","unstructured":"Lowe C, Katz K, McGeer A, Muller MP, Toronto ESBL, Working Group. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control. 2012;40:836\u20139.","journal-title":"Am J Infect Control"},{"key":"267_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ajic.2011.05.022","volume":"40","author":"A Borer","year":"2012","unstructured":"Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae. Am J Infect Control. 2012;40:421\u20135.","journal-title":"Am J Infect Control"},{"key":"267_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jmii.2012.08.029","volume":"47","author":"SR Huang","year":"2014","unstructured":"Huang SR, Liu MF, Lin CF, Shi ZY. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections. J Microbiol Immunol Infect. 2014;47:187\u201396.","journal-title":"J Microbiol Immunol Infect"},{"key":"267_CR7","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1128\/AAC.01325-08","volume":"53","author":"Y Liu","year":"2009","unstructured":"Liu Y, Zhang B, Cao Q, Huang W, Shen L, Qin X. Two clinical strains of Klebsiella pneumoniae carrying plasmid-borne bla\n                           IMP-4, bla\n                           SHV-12, and armA isolated at a Pediatric Center in Shanghai, China. Antimicrob Agents Chemother. 2009;53:1642\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"267_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1128\/AAC.01099-09","volume":"54","author":"Q Yang","year":"2010","unstructured":"Yang Q, Wang H, Sun H, Chen H, Xu Y, Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob Agents Chemother. 2010;54:573\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"267_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1086\/592412","volume":"29","author":"G Patel","year":"2008","unstructured":"Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099\u2013106.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"267_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","volume":"37","author":"DM Livermore","year":"2011","unstructured":"Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37:415\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"267_CR11","volume-title":"Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement M100","author":"CLSI","year":"2016","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement M100. Wayne: Clinical and Laboratory Standards Institute; 2016."},{"key":"267_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4314\/ahs.v16i1.21","volume":"16","author":"F Pang","year":"2016","unstructured":"Pang F, Jia XQ, Song ZZ, Li YH, Wang B, Zhao QG, et al. Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital. Afr Health Sci. 2016;16:153\u201361.","journal-title":"Afr Health Sci"},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101:1644\u201355.","journal-title":"Chest"},{"key":"267_CR14","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s10096-016-2710-0","volume":"35","author":"Q Wang","year":"2016","unstructured":"Wang Q, Zhang Y, Yao X, Xian H, Liu Y, Li H, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35:1679\u201389.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"267_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/AAC.01775-15","volume":"60","author":"AM Ocampo","year":"2015","unstructured":"Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, et al. A two-year surveillance in five Colombian Tertiary Care Hospitals reveals high frequency of Non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother. 2015;60:332\u201342.","journal-title":"Antimicrob Agents Chemother"},{"key":"267_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/cid\/cis543","volume":"55","author":"LK Logan","year":"2012","unstructured":"Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis. 2012;55:852\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"267_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.burns.2012.02.025","volume":"39","author":"A Rastegar Lari","year":"2013","unstructured":"Rastegar Lari A, Azimi L, Rahbar M, Fallah F, Alaghehbandan R. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns. 2013;39(1):174\u20136.","journal-title":"Burns"},{"key":"267_CR18","doi-asserted-by":"publisher","first-page":"148ra116","DOI":"10.1126\/scitranslmed.3004129","volume":"4","author":"ES Snitkin","year":"2012","unstructured":"Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program Group, Henderson DK, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4:148ra116.","journal-title":"Sci Transl Med"},{"key":"267_CR19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1099\/jmm.0.043000-0","volume":"61","author":"F Yu","year":"2012","unstructured":"Yu F, Ying Q, Chen C, Li T, Ding B, Liu Y, et al. Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China. J Med Microbiol. 2012;61:984\u20139.","journal-title":"J Med Microbiol"},{"key":"267_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3343\/alm.2012.32.4.270","volume":"32","author":"Y Xia","year":"2012","unstructured":"Xia Y, Liang Z, Su X, Xiong Y. Characterization of carbapenemase genes in Enterobacteriaceae species exhibiting decreased susceptibility to carbapenems in a university hospital in Chongqing, China. Ann Lab Med. 2012;32:270\u20135.","journal-title":"Ann Lab Med"},{"key":"267_CR21","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1128\/JCM.05297-11","volume":"49","author":"BM Limbago","year":"2011","unstructured":"Limbago BM, Rasheed JK, Anderson KF, Zhu W, Kitchel B, Watz N, et al. IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J Clin Microbiol. 2011;49:4239\u201345.","journal-title":"J Clin Microbiol"},{"key":"267_CR22","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1128\/AAC.00402-12","volume":"56","author":"EA Neuner","year":"2012","unstructured":"Neuner EA, Sekeres J, Hall GS, van Duin D. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother. 2012;56:5744\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"267_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","volume":"69","author":"EA Neuner","year":"2011","unstructured":"Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011;69:357\u201362.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"267_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2012.11.009","volume":"75","author":"D Duin van","year":"2013","unstructured":"van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75:115\u201320.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1128\/AAC.01695-15","volume":"60","author":"N Kohira","year":"2015","unstructured":"Kohira N, West J, Ito A, Ito-Horiyama T, Nakamura R, Sato T, et al. In Vitro Antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob Agents Chemother. 2015;60:729\u201334.","journal-title":"Antimicrob Agents Chemother"},{"key":"267_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/mdr.2015.0311","volume":"23","author":"LF Huang","year":"2017","unstructured":"Huang LF, Lee CT, Su LH, Chang CL. A snapshot of co-resistance to carbapenems and tigecycline in clinical isolates of Enterobacter cloacae. Microb Drug Resist. 2017;23:1\u20137.","journal-title":"Microb Drug Resist"},{"key":"267_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1469-0691.2011.03553.x","volume":"17","author":"GL Daikos","year":"2011","unstructured":"Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect. 2011;17:1135\u201341.","journal-title":"Clin Microbiol Infect"},{"key":"267_CR28","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1128\/AAC.01420-10","volume":"55","author":"CC Bulik","year":"2011","unstructured":"Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55:3002\u20134.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-018-0267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12941-018-0267-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-018-0267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T20:12:02Z","timestamp":1553285522000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-018-0267-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1186\/s12941-018-0267-8","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,23]]},"assertion":[{"value":"31 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}